OmniComm and MediStat Expand Presence in Israel
OmniComm Systems and MediStat have collaborated to expand their life sciences market presence in Israel.
OmniComm Systems and MediStat have collaborated to expand their life sciences market presence in Israel. Under this agreement, OmniComm’s TrialMaster EDC suite will be used to fulfill the clinical trial needs of the Israeli life sciences sector.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025